tiprankstipranks
Eledon Pharmaceuticals (ELDN)
NASDAQ:ELDN
US Market
ELDN
Eledon Pharmaceuticals
RESEARCH TOOLSreports
Want to see ELDN full AI Analyst Report?

Eledon Pharmaceuticals (ELDN) Income Statement

1,029 Followers

Eledon Pharmaceuticals Income Statement

Last quarter (Q4 2025), Eledon Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Eledon Pharmaceuticals's net income was $-10.45M. See Eledon Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -359.00K$ -374.00K$ -373.00K$ -195.00K
Operating Expenses
$ 83.25M$ 70.22M$ 42.63M$ 39.41M$ 36.67M
Depreciation and Amortization
$ 0.00$ 359.00K$ 374.00K$ 373.00K$ 195.00K
EBITDA
$ -83.25M$ -35.39M$ -116.16M$ -87.59M$ -36.66M
Operating Income
$ -83.25M$ -70.58M$ -43.00M$ -39.78M$ -36.87M
Other Income/Expenses
$ 37.67M$ 34.82M$ -73.54M$ -48.19M$ 7.00K
Pretax Income
$ -45.58M$ -35.75M$ -116.54M$ -87.97M$ -36.86M
Net Income
$ -45.62M$ -36.18M$ -116.54M$ -87.97M$ -34.51M
Per Share Metrics
Basic EPS
$ -0.56$ -0.75$ 0.00$ -6.13$ -2.33
Diluted EPS
$ -0.56$ -0.75$ -1.64$ -6.13$ -2.33
Weighted Average Shares Outstanding
 81.84M 48.54M 24.62M 14.29M 14.82M
Weighted Average Shares Outstanding (Diluted)
 81.84M 48.54M 24.62M 14.29M 14.82M
Currency in USD

Eledon Pharmaceuticals Earnings and Revenue History